These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23765731)

  • 21. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate epithelial-specific expression of activated PI3K drives stromal collagen production and accumulation.
    Wegner KA; Mueller BR; Unterberger CJ; Avila EJ; Ruetten H; Turco AE; Oakes SR; Girardi NM; Halberg RB; Swanson SM; Marker PC; Vezina CM
    J Pathol; 2020 Feb; 250(2):231-242. PubMed ID: 31674011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.
    Shan S; Su M; Li Y; Wang Z; Liu D; Zhou Y; Fu X; Yang S; Zhang J; Qiu J; Liu H; Zeng G; Chen P; Wang X; DiSanto ME; Guo Y; Zhang X
    Mol Med; 2023 Oct; 29(1):139. PubMed ID: 37864185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin.
    Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N
    J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of prostate cell growth and morphogenesis by Dickkopf-3.
    Kawano Y; Kitaoka M; Hamada Y; Walker MM; Waxman J; Kypta RM
    Oncogene; 2006 Oct; 25(49):6528-37. PubMed ID: 16751809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
    Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
    PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.
    Sampson N; Koziel R; Zenzmaier C; Bubendorf L; Plas E; Jansen-Dürr P; Berger P
    Mol Endocrinol; 2011 Mar; 25(3):503-15. PubMed ID: 21273445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis.
    Yuan S; Hoggard NK; Kantake N; Hildreth BE; Rosol TJ
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.
    Franco OE; Jiang M; Strand DW; Peacock J; Fernandez S; Jackson RS; Revelo MP; Bhowmick NA; Hayward SW
    Cancer Res; 2011 Feb; 71(4):1272-81. PubMed ID: 21303979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.
    Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L
    Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
    Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
    Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.